Literature DB >> 9845540

Interleukin-10 suppresses IP-10 gene transcription by inhibiting the production of class I interferon.

J M Tebo1, H S Kim, J Gao, D A Armstrong, T A Hamilton.   

Abstract

Interleukin-10 (IL-10) selectively inhibited lipopolysaccharide (LPS)-induced chemoattractant cytokine gene expression: levels of IP-10 mRNA were markedly suppressed in IL-10-treated mouse peritoneal macrophages, whereas the expression of the RANTES mRNA was only modestly reduced. IL-10 inhibited IP-10 mRNA accumulation by reducing IP-10 gene transcription as demonstrated by nuclear run-on analysis. Interestingly, the ability of IL-10 to inhibit expression of IP-10 was dependent on the inducing stimulus; IL-10 did not suppress interferon gamma (IFNgamma)- or IFNbeta-stimulated IP-10 transcription or mRNA accumulation. These results suggested that IL-10 might act indirectly to suppress IP-10 expression by inhibiting LPS-induced class I IFN production. This hypothesis was supported by the following observations. First, LPS-induced IP-10 mRNA expression was blocked in cells cotreated with cycloheximide. Second, IL-10 inhibited the production of IFN/beta-mediated antiviral activity. Finally, the IL-10-mediated suppression of LPS-stimulated IP-10 production could be rescued by cotreatment with IFNbeta.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9845540

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Toll-like Receptor 3 Is a Therapeutic Target for Pulmonary Hypertension.

Authors:  Daniela Farkas; A A Roger Thompson; Aneel R Bhagwani; Schuyler Hultman; Hyun Ji; Naveen Kotha; Grant Farr; Nadine D Arnold; Adam Braithwaite; Helen Casbolt; Jennifer E Cole; Ian Sabroe; Claudia Monaco; Carlyne D Cool; Elena A Goncharova; Allan Lawrie; Laszlo Farkas
Journal:  Am J Respir Crit Care Med       Date:  2019-01-15       Impact factor: 21.405

2.  Negative regulation of Toll-like receptor 4 signaling by IL-10-dependent microRNA-146b.

Authors:  Graziella Curtale; Massimiliano Mirolo; Tiziana Ada Renzi; Marzia Rossato; Flavia Bazzoni; Massimo Locati
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-24       Impact factor: 11.205

3.  CXCL10 production from cytomegalovirus-stimulated microglia is regulated by both human and viral interleukin-10.

Authors:  Maxim C-J Cheeran; Shuxian Hu; Wen S Sheng; Phillip K Peterson; James R Lokensgard
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

4.  Advanced glycation end-products reduce lipopolysaccharide uptake by macrophages.

Authors:  Atsuhiro Kitaura; Takashi Nishinaka; Shinichi Hamasaki; Omer Faruk Hatipoglu; Hidenori Wake; Masahiro Nishibori; Shuji Mori; Shinichi Nakao; Hideo Takahashi
Journal:  PLoS One       Date:  2021-01-25       Impact factor: 3.240

5.  Infection of human dendritic cells with a Mycobacterium tuberculosis sigE mutant stimulates production of high levels of interleukin-10 but low levels of CXCL10: impact on the T-cell response.

Authors:  Elena Giacomini; Ambar Sotolongo; Elisabetta Iona; Martina Severa; Maria Elena Remoli; Valerie Gafa; Roberto Lande; Lanfranco Fattorini; Issar Smith; Riccardo Manganelli; Eliana M Coccia
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

6.  Interleukin-7 (IL-7) treatment accelerates neutrophil recruitment through gamma delta T-cell IL-17 production in a murine model of sepsis.

Authors:  Kevin R Kasten; Priya S Prakash; Jacqueline Unsinger; Holly S Goetzman; Lisa G England; Cindy M Cave; Aaron P Seitz; Cristina N Mazuski; Tony T Zhou; Michel Morre; Richard S Hotchkiss; David A Hildeman; Charles C Caldwell
Journal:  Infect Immun       Date:  2010-09-07       Impact factor: 3.441

7.  Interferon-induced protection against foot-and-mouth disease virus infection correlates with enhanced tissue-specific innate immune cell infiltration and interferon-stimulated gene expression.

Authors:  Fayna Diaz-San Segundo; Mauro P Moraes; Teresa de Los Santos; Camila C A Dias; Marvin J Grubman
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

8.  Deletion of nonstructural proteins NS1 and NS2 from pneumonia virus of mice attenuates viral replication and reduces pulmonary cytokine expression and disease.

Authors:  Ursula J Buchholz; Jerrold M Ward; Elaine W Lamirande; Britta Heinze; Christine D Krempl; Peter L Collins
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

Review 9.  Regulation of chemokine expression by antiinflammatory cytokines.

Authors:  Thomas A Hamilton; Yoshihiro Ohmori; Julie Tebo
Journal:  Immunol Res       Date:  2002       Impact factor: 4.505

10.  Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: impact on chronic inflammation.

Authors:  Gabriele Hoermannsperger; Gabriele Hörmannsperger; Thomas Clavel; Micha Hoffmann; Caroline Reiff; Denise Kelly; Gunnar Loh; Michael Blaut; Gabriele Hölzlwimmer; Melanie Laschinger; Dirk Haller
Journal:  PLoS One       Date:  2009-02-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.